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This work presents a novel method for detecting nu-
cleic acid targets using a ligation step along with an
isothermal, exponential amplification step. We use an
engineered ssDNA with two variable regions on the
ends, allowing us to design the probe for optimal
reaction kinetics and primer binding. This two-part
probe is ligated by T4 DNA Ligase only when both
parts bind adjacently to the target. The assay demon-
strates that the expected 72-nt RNA product appears
only when the synthetic target, T4 ligase, and both
probe fragments are present during the ligation step.
An extraneous 38-nt RNA product also appears due to
linear amplification of unligated probe (P3), but its
presence does not cause a false-positive result. In ad-
dition, 40 mmol/L KCl in the final amplification mix
was found to be optimal. It was also found that in-
creasing P5 in excess of P3 helped with ligation and
reduced the extraneous 38-nt RNA product. The assay
was also tested with a single nucleotide polymor-
phism target, changing one base at the ligation site.
The assay was able to yield a negative signal despite
only a single-base change. Finally, using P3 and P5
with longer binding sites results in increased overall
sensitivity of the reaction, showing that increasing
ligation efficiency can improve the assay overall. We
believe that this method can be used effectively for a
number of diagnostic assays. (J Mol Diagn 2012, 14:
206-213; DOI: 10.1016/j.jmoldx.2012.01.004)
Various methods have been researched in disease diag-
nostics, but there are limitations to these methods. In the
case of influenza, techniques such as viral culture, anti-
gen tests, immunofluorescence microscopy, and nucleic
acid amplification have been thoroughly investigated. Vi-
ral culture has great specificity,1 but results take 3 to 14
days, limiting its use in rapid diagnostics.2 Rapid antigen
206tests and immunofluorescence microscopy give fast an-
swers, but these tests lack specificity and do not provide
information on subtyping.3 Use of nucleic acid tests with
amplification is currently the best approach to solving this
problem. PCR requires only 3 hours of amplification
time, but expensive thermal cyclers and trained techni-
cians are required to carry out the test.2 Loop-mediated
isothermal amplification has also been used to rapidly
amplify DNA targets, but design can be difficult, as a total
of six primers recognizing 10 distinct sequences are
needed.4 Nucleic acid sequence–based amplification
(NASBA) takes less time than PCR for RNA amplification
and has been shown to be effective in detecting HIV RNA
clinical samples.5,6 It is limited, however, by the second-
ary structure of RNA, which constrains primer design.7
This in turn decreases the number of conserved regions
that can be used as NASBA priming sites. In addition,
primer sites for NASBA are chosen to be between 100
and 250 nucleotides apart to decrease secondary struc-
ture of the amplified product.8
Ligation has been used in previous amplification reac-
tions to improve sensitivity and to achieve better multi-
plexing. One group of these is known as the ligase chain
reaction (LCR), which in general involves ligating two
adjacent primers to one strand of target DNA. This new
oligonucleotide can then serve as another template for
another ligation event with the reverse complementary
primers, leading to exponential amplification.9,10 There
are other variations of this technique as well, including
polymerase chain reaction–linked ligase chain reaction
and gapped LCR.11 In addition, others have incorporated
a ligation step with an amplification step. Hsuih et al used
ligation and PCR to perform ligation-dependent PCR to
detect hepatitis C virus RNA in serum.12 Reijans et al
described a multiplex ligation-dependent probe amplifi-
cation method that also uses ligation and PCR to develop
an assay for detecting 15 respiratory viruses in a single
reaction.13 Tyagi et al combined a ligation step with am-
plification via Q replicase. Ligation between two RNA
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circle amplification has been used in conjunction with
ligated padlock probes to yield long single-stranded
DNA as the amplified product.15
We demonstrate a ligation assay incorporated with
NASBA, which we call ligation with nucleic acid se-
quence–based amplification (LNASBA). LNASBA uses
an engineered ssDNA probe that binds to a conserved
region of the RNA target, after which the probe is ampli-
fied via NASBA. The binding portion of the probe is
flanked by two variable regions, giving the user great
flexibility in designing the amplifiable probe and primer
sequences, which can be used to reduce secondary
structure to optimize reaction kinetics. In addition, a liga-
tion step has been added, which increases specificity
and ensures that only a single conserved region is
needed for amplification. To incorporate this ligation step,
the ssDNA probe is split into two parts that are ligated
together by T4 DNA Ligase only when both parts are
bound next to each other on the target. Although the
buffer for ligation differs from that for conventional
NASBA, amplification conditions can be made by adding
Figure 1. A:Diagram of the LNASBA assay with a ligation step. Ligation occurs
probe. The probe is then amplified using three enzymes (AMV-RT, T7 RNA polymerase
to nonligated P3 to generate amplification of a shorter RNA product. Note that this leadthe correct buffer, and thus the protocol represents a
single tube amplification method.
This article describes a number of experiments that
show the viability of this method in addition to optimiza-
tions. Using a synthetic target, ligation followed by am-
plification and detection were shown to occur as ex-
pected. In addition, optimization of amplification was
studied by investigating the effect of varying KCl concen-
trations and probe fragment concentrations. We investi-
gate our assay’s ability to detect single nucleotide poly-
morphisms (SNPs) by mutating a single nucleotide on the
target and comparing the results with samples of the fully
complementary target.
Materials and Methods
Design of LNASBA
The complete method involves a ligation step followed by
a cyclic, isothermal, exponential amplification step (Fig-
ure 1A). In the ligation step, the two fragments of the
amplifiable probe, Probe 3= (P3) and Probe 5= (P5) hy-
the two probe fragments (P3 and P5) with T4 DNA ligase, to form the full-lengthbetween
, and RNase H) and two primers. B: Side amplification product. Primer 1 binds
s to a linear amplification rather than to an exponential, cyclical amplification.
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phosphate at its 5= end, so that when P3 and P5 are
bound beside each other with the phosphate in the mid-
dle, T4 DNA Ligase joins the two fragments, yielding a
full-length amplifiable probe. This probe then enters the
amplification cycle, a 90 minute step at 41°C using three
enzymes (AMV reverse transcriptase, T7 RNA polymer-
ase, and RNase H) and two primers (P1 and P2). Ampli-
fication follows similarly to standard NASBA, except the
starting substrate is the ligated ssDNA probe rather than
the RNA target. Detection can be performed in different
ways, including molecular beacons and gel electropho-
resis. For these experiments, gel electrophoresis was the
primary means of detection and quantification.
Design of LNASBA Probes, Primers, and Targets
Custom oligonucleotides (Table 1) were purchased from
Integrated DNA Technologies, Inc. (Coralville, IA). The full
probe was first designed to be reverse complementary to
synthesized target DNA. This target DNA was chosen to be
a 19-nucleotide sequence that was previously shown to be
a conserved and appropriate site for molecular beacon
hybridization.16 The flanking sequences of the probe were
chosen to minimize secondary structure. An online folding
tool (UNAFold on The DINAMelt Server, SUNY Albany) was
used to find probes and primers with minimized secondary
structure at the binding sites. P3 and P5 were made by
splitting the probe in the middle, and a phosphate group is
present on the 5= end of P3 to facilitate ligation. The SNP
Target was designed by taking the current Target and re-
placing a thymine base with a guanine at the ligation site.
To investigate the effect of a longer binding site, an ex-
tended oligo set (H5C1185) was also created (Table 1) in
which seven nucleotides were added each to P3 and P5,
called xP3 and xP5. These bind to an extended target
(xTarget) that is 14 nucleotides longer than the original
Target (H5G1192). The additional 14 nucleotides are re-
Table 1. Oligonucleotides Used in the Assay
Oligo
H5G1192 probe set
Target 5=-GTGACTCCAtCTATTGCCT-3
SNP Target 5=-GTGACTCCAgCTATTGCCT-3
Probe 5=-TCAAGAGTAGACACCTGTTACC
Probe 5= (P5) 5=-TCAAGAGTAGACACCTGTTAC
Probe 3= (P3) 5=-/5Phos/ATGGAGTCACGTAA
H5C1185 Probe Set
Extended Target 5=-CTTATTGGTGACTCCATCTAT
Extended Probe 5=-TCAAGAGTAGACACCTGTTACC
AGATCAGAGCAATAGGTCA-3=
Extended Probe 5= (xP5) 5=-TCAAGAGTAGACACCTGTTAC
Extended Probe 3= (xP3) 5=-/5Phos/ATGGAGTCACCAAT
Primers
Primer 1 (P1) 5=-TAATACGACTCACTATAGGGT
Primer 2 (P2) 5=-TCAAGAGTAGACACCTGTTAC
Transcribed RNA
72 nt Product 5=-GGGUGACCUAUUGCUCUGAUCU
38 nt Product 5=-GGGUGACCUAUUGCUCUGAUC
Probes and primers are made to target H5 influenza vRNA, but ssDNA
the target-binding site, and the lowercase nucleotides highlight the difference b
polymerase promoter. Bold regions correspond to Primer 1-binding sites.verse complementary to the additional nucleotides of xP3
and xP5. The primer binding regions remained unchanged.
Ligation Reactions
All reactions were run in 200-L polypropylene tubes. A
20-L ligation mix was first prepared with 1X NEB T4
DNA Ligase Buffer (50 mmol/L Tris-HCl, 10 mmol/L
MgCl2, 1 mmol/L ATP, 10 mmol/L DTT, pH 7.5, at 25°C),
5 U/L T4 DNA Ligase (New England BioLabs, Ipswich,
MA), and varied concentrations of P5, P3, and Target.
This mix is placed into a Bio-Rad MyCycler thermal cycler
(Bio-Rad, Hercules, CA) at 16°C for 20 minutes, and then
is heated to 65°C for 20 minutes to inactivate T4 DNA
Ligase. To reduce reagent use, 5 L of each sample is
saved and used in the amplification step.
NASBA Reactions
Both a reaction mix and an enzyme mix are prepared for
20-L amplification reactions. For each sample, 11.25 L
of reaction mix is added to the 5-L sample such that the
final concentrations are 40 mmol/L Tris (pH 8.0), 12
mmol/L MgCl2, between 40 and 75 mmol/L KCl, 5 mmol/L
DTT, 0.25 mmol/L ATP, 1 mmol/L each dNTP (NEB), 2
mmol/L each rNTP (New England BioLabs, Ipswich, MA),
0.2 mol/L Primer 1, 0.2 mol/L Primer 2, and 2.46
mmol/L NaOH. The LNASBA buffer includes 1 mmol/L
ATP present from the ligation reaction and 2.46 mmol/L
NaOH, used to correct the pH for the NASBA reaction
cycle (pH 8.0). The amount of NaOH added was deter-
mined by the Henderson–Hasselbalch equation. In some
control reactions, no ligation step is performed before
amplification, and in these cases, the 0.25 mmol/L ATP
and 2.46 mmol/L NaOH are not present in the reaction
mix, as T4 DNA Ligase Buffer is not used beforehand.
This mix is placed in a thermal cycler and heated to 65°C
for 5 minutes, then to 41°C for 5 minutes. A 3.75-L
Sequence
GCAATAGATGGAGTCACGTAATCAGATCAGAGCAATAGGTCA-3=
GGCAATAG-3=
TCAGAGCAATAGGTCA-3=
TTTGAGT-3=
TCAAAAGGCAATAGATGGAGTCACCAATAAGGTAATC-
CTCAAAAGGCAATAG-3=
AATCAGATCAGAGCAATAGGTCA-3=
ATTGCTCTGATCTGATTAC-3=
3=
CGUGACUCCAUCUAUUGCCUAUCGGUAACAGGUGUCUACUCUUGA-3=
ACGUGACUCCAU-3=
tic target is used as a proof-of-concept. Underlined letters correspond to=
=
GATAG
CGATA
TCAGA
TGCCT
GATAC
CGATA
AAGGT
GACCT
CGAT-
GAUUA
UGAUU
synthe
etween target and SNP target. The italicized region denotes the T7 RNA
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centrations are 0.33 U/L AMV-RT, 0.01 U/L RNase H,
1.6 U/L T7 RNA polymerase, and 0.11 g/L bovine
serum albumin (New England BioLabs). The samples are
kept at 41°C for 90 minutes, and the reaction is stopped
by freezing the samples. Detection and quantification was
performed by diluting the sample 1:5 in RNase-free water
before electrophoresis with the Agilent Small RNA Kit with
the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA). The Agilent 2100 bioanalyzer separates nucleic
acid fragments in microfabricated channels and automates
detection as well as on-line data evaluation. The software
package includes data collection, presentation, and inter-
pretation functions. Data can be displayed as a gel-like
image and/or as electropherogram(s).
Results
LNASBA Assay
To confirm that the assay works as designed, experi-
ments were performed varying the presence of full-length
Probe, P3, P5, Target, and T4 DNA Ligase. When pres-
ent, Probe, Target, P3, and P5 concentrations were 0.15
mol/L each. KCl concentration for the amplification step
was 70 mmol/L. Figure 2 summarizes the results in a
pseudogel plot of nucleic acid products. Lanes 1 and 2
contain full-length Probe to serve as positive controls,
showing where the expected 72-nt product appears in
gel electrophoresis. Lane 2 differs from lane 1 in that
Target and T4 DNA Ligase are introduced into the reac-
tion mix. Lanes 3 through 5 show the experimental con-
ditions. When all of the components of the ligation mix
were present (lane 3), amplification of the expected 72 nt
RNA product occurred. However, partial ligation mixes
that were missing either Target (lane 4) or T4 DNA Ligase
(lane 5) resulted in no amplification of 72 nt RNA. These two
lanes confirm that both Target and T4 DNA Ligase are
necessary for ligation of P3 and P5 into complete probe,
Figure 2. Sample with probe alone (positive control) generates expected
band at 72 nt, confirming that amplification is occurring. Boxed area confirms
that ligation occurs only when P3/P5/target/T4 each are present. The product
at 38 nt is a result of Primer 1 (containing T7 promoter) binding to nonligated
P3, which can result in amplification of RNA with shorter sequence.which can then undergo cyclic amplification.We note that an additional 38-nt RNA product was
produced in all of the reactions that incorporated P3 and
P5 (lanes 3 to 5). This occurs because Primer 1, which
contains the T7 promoter, will still bind to nonligated P3,
allowing transcription of shorter RNA product (Figure 1B).
However, this does not affect detection with either gel
electrophoresis, because of the size difference, or mo-
lecular beacons, which can be designed to bind to the
other end of the RNA product. In addition, this side prod-
uct amplification is only linear, as no reverse primer (P2)
can bind in this reaction. We further note that, with our
designed probes and primers, only RNA sequences of
exactly 38 and 72 nt can be transcribed. These tran-
scribed sequences are now shown in Table 1.
The sensitivity of the assay was also investigated.
While the P3 and P5 concentrations were held constant at
150 nmol/L, the concentrations of Target were varied
from 0 nmol/L to 1500 nmol/L. Results are presented on a
log–log graph (Figure 3). At 0 nmol/L of Target, no de-
tectable concentration of nucleic acid around the 72-nt
range appeared and thus does not appear on the graph.
There is a positive correlation between the starting con-
centration of Target and the concentration of 72 nt RNA
product until a plateau is reached. We believe that the
limiting reagent is Primer 1 at 0.2 mol/L, as it can be
consumed by P3 that has not been ligated into full-length
Probe. Furthermore, it should be noted that the product
concentration is roughly only one order of magnitude
greater than the Target concentration at any point, which
implies that much optimization is needed. However, this
experiment proves that the concept of combining ligation
with the NASBA assay is viable.
Optimization of KCl Concentration in
Amplification Step
One way to improve the assay is to improve the efficiency
of the amplification step. It has been shown previously
that T7 RNA polymerase is highly sensitive to salts, and
that its efficiency is positively correlated with decreasing
chloride concentrations down to 10 mmol/L KCl.17 Fur-
Figure 3. Log–log plot of the concentration of 72-nt RNA as a function of the
starting concentration of target. P3 and P5 concentrations were fixed at 150
nmol/L for all conditions. As the concentration of target increases, the con-
centration of 72-nt RNA increases and levels off.
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chloride concentrations between 50 and 150 mmol/
L,18,19 and AMV-RT is optimized with KCl concentrations
between 50 and 100 mmol/L.20 Thus, finding the optimal
balance of salt conditions to improve the overall amplifi-
cation reaction is important. We investigated the effect of
varying the concentration of KCl between 40 mmol/L and
75 mmol/L. Target concentration was 80 nmol/L, and P3
and P5 concentrations were each 150 nmol/L. A ligation
step, followed by amplification, was carried out. The data
show that there was an increase in product as KCl con-
centration decreased down to 40 mmol/L (Figure 4).
Given these data, we believe that the increased T7
RNA polymerase activity is an important contributor in
this increased signal, overcoming possible decreased
activity of AMV-RT and RNase H. However, this might
differ, given a lower starting concentration of Target, as
AMV-RT and RNase H are key components in the cyclic
portion of NASBA. To investigate this further, an experi-
ment focusing on only amplification of full-length Probe
was performed. Full-length Probe at 10 nmol/L and 100
pmol/L was amplified without a ligation step at 40 mmol/L
and 70 mmol/L KCl, and at both conditions, it is more
optimal to have 40 mmol/L KCl as a final concentration
compared with 70 mmol/L KCl (see Supplemental Figure
S1 at http://jmd.amjpathol.org).
Effect of Varying P3 and P5 Concentrations
Because amplification of the shorter, 38-nt RNA product
is caused by linear amplification of free P3 in solution,
one way to decrease this secondary amplification and to
optimize the intended reaction is to increase the effi-
ciency of ligation. P3 and P5 are critical components of
this assay, and we investigated the effect of varying the
ratio between P3 and P5 by changing the starting con-
centration of P5 between 0 and 0.65 mol/L, hypothesiz-
ing that increasing P5 in relation to P3 will lead to fewer
free P3 in solution, as more will be incorporated into full
length Probe due to improved ligation. Target and P3
concentrations were held constant at 0.15 mol/L, and a
Figure 4. Concentration of 72-nt RNA product plotted as a function of KCl
concentration. Standard amplification reaction conditions were used,
whereas KCl concentration was varied from 40 to 70 mmol/L. Target con-
centration was 80 nmol/L, and P3 and P5 concentrations were each 150
nmol/L. Of the conditions tested, 40 mmol/L was the optimal final concen-
tration of KCl for efficient amplification.ligation step was followed by amplification. Amplificationconditions used the 40 mmol/L KCl concentration from
the previous section. Results (Figure 5) show that in-
creasing P5 leads to an increase in the desired 72 nt RNA
product and a decrease of the extraneous 38 nt RNA
product until a plateau occurs. It is important to note,
though, that excessive P5 does not appear to hinder the
reaction, and improves ligation as well as serving as an
additional source for Primer 2 if exhausted. The data also
imply that a ratio of at least 3.66:1 of P5 to P3 is needed
to optimize ligation and amplification.
Because of the plateau in both curves, the data imply
that there is a limiting reagent preventing a stronger sig-
nal. As Primer 1 is being consumed by unbound P3 and
is also a key component in the amplification step, it is the
most probable limiting reagent. Thus, it is likely that in-
creasing Primer 1 would increase the amount of free
Primer 1 available during amplification.
Effect of Varying P1 Concentration
Because Primer 1 may be a limiting reagent during am-
plification, a series of experiments were carried out to
evaluate the effect of Primer 1 concentration on amplifi-
cation. In Figure 6, we see that the concentration of 72 nt
RNA Product continually increases as Primer 1 concen-
tration in the reaction mix increases. The concentration of
38 nt RNA product also follows the same upward trend,
but plateaus early on when Primer 1 is at a concentration
of 0.2 mol/L. This may be due to free P3 being saturated
by P1, which is possible since P3 concentration is fixed.
However, the concentration of full-length probe is not
fixed due to the cyclic nature of amplification (Figure 1A),
preventing saturation by P1. This is likely why the con-
centration of 72 nt RNA product continues to increase as
P1 concentration increases. When P1 is approximately
0.35 mol/L, 72-nt product concentration surpasses that
of 38-nt product, indicating that cyclic amplification be-
gins to dominate the linear amplification side reaction.
Figure 5. The effect of adjusting P5 concentration on the concentration of
the two RNA products created. Target and P3 concentrations were each 150
nmol/L, and KCl concentration was 40 mmol/L for all conditions. P5 con-
centration was varied between 0 nmol/L and 650 nmol/L. Increased P5
concentration yields a higher concentration of 72-nt RNA and a lower con-
centration of 38-nt RNA until a plateau is reached.
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The ligation step may also be improved in addition to
increasing P5 concentration by increasing the number of
bp that P3 and P5 have to bind to the target sequence. P3
and P5 from the H5G1192 probe set bind to Target with
10 and 9 nucleotides, respectively, which may lead to
inefficient binding. Therefore an extended probe set was
created (Table 1) in which seven nucleotides were added
each to P3 and P5, called xP3 and xP5, which bind to an
extended target (xTarget) that is 14 nucleotides longer
than the original Target.
We performed a series of experiments (Figure 7) in
which the assay was carried out with both the original
oligo set H5G1192 and the extended oligo set H5C1185
with serial dilutions of Target or xTarget, respectively.
These were done with the optimized conditions that we
have found and discussed thus far in this article. Target
and xTarget concentrations were varied from 0 to 100
nmol/L; P3 and xP3 concentrations were 150 nmol/L; P5
and xP5 concentrations were 650 nmol/L; KCl concentra-
tion was 40 mmol/L; P1 concentration was 0.6 mol/L;
and P2 concentration was 0.2 mol/L. The extended set
produces 86-nt RNA product, as designed.
In Figure 7, we see that the concentration of RNA
product produced from the extended oligo set H5C1185
increases at a faster rate than that produced from the
original oligo set H5G1192. We also notice that the 86-nt
RNA product of H5C1185 is higher at a lower Target
concentration, suggesting that our assay is more sensi-
tive with the extended probes, likely because of in-
creased binding efficiency. According to Figure 7, the
limit for detection for the oligo set H5G1192 is on the
order of 1 nmol/L, and for H5C1185, it is on the order of
100 pmol/L.
SNP Detection
To test the ability of the assay to differentiate SNPs,
Figure 6. The effect of varying Primer 1 (P1) concentration on the concen-
tration of the two RNA products created. KCl concentration was 40 mmol/L;
target and P3 concentrations were 150 nmol/L; P5 concentration was 650
nmol/L; P2 concentration was 0.2 mol/L; and P1 concentration was varied
from 0 to 0.5 mol/L. Increasing P1 concentrations corresponded with a
steady increase in 72-nt RNA product concentration, whereas 38-nt RNA
product concentration reached a plateau.experiments were performed using either Target or SNPTarget at a concentration of 0.15 mol/L with the original
oligo set, H5G1192. In addition, the concentrations of P3
and P5 were varied from 0 to 0.35 mol/L to also inves-
tigate the effect of increasing their concentrations. A
pseudogel is presented in Figure 8A.
The pseudogel shows the expected band appearing
only when Target is used as the substrate (lanes 4, 6, and
8), and the band is notably missing from conditions using
the SNP Target (lanes 3, 5, and 7). The pseudogel also
shows that the 72-nt band is actually lighter with increas-
ing P3 and P5 concentrations (lanes 4, 6, and 8). In a
conventional gel, this would imply lower amounts of prod-
uct; however, this is an artifact of the normalization algo-
rithm of the Bioanalyzer Small RNA Series II analysis
program. Instead of band intensity being normalized
across a gel, the program normalizes intensity by the
band with the greatest intensity, or equivalently concen-
tration of nucleotide product, in each lane. Inspection of
the concentrations in the program confirms that the con-
centration of 72-nt RNA does indeed increase with in-
creasing P3 and P5 concentrations (Figure 8B).
Discussion
The work presented here proposes and demonstrates a
novel method, LNASBA, for amplification and detection of
various nucleic acid targets through ligation and engi-
neered probes, using the advantages of both ligation and
NASBA in a single tube assay. This was achieved by
designing the amplifiable probe to have two variable
regions flanking the binding region of the ssDNA. Be-
cause both of these regions are crucial to the cyclic,
exponential amplification in NASBA, we can use ligation
Figure 7. The effect of increasing binding site length for P3 and P5.
H5G1192 corresponds with the original oligo set, whereas H5C1185 corre-
sponds with the extended oligo set. Target and xTarget concentrations were
varied from 0 to 100 nmol/L; P3 and xP3 concentrations were 150 nmol/L; P5
and xP5 concentrations were 650 nmol/L; KCl concentration was 40 mmol/L;
P1 concentration was 0.6 mol/L; and P2 concentration was 0.2 mol/L. The
extended probe set (H5C1185) produces 86-nt RNA product, and the original
probe set (H5G1192) produces 72-nt RNA product. The concentration of RNA
product produced with the extended probe set (H5C1185) increases at a
higher rate and produces higher concentrations of product than of those
produced with the original probe set (H5G1192). The limit for detection for
the oligo set H5G1192 is on the order of 1 nmol/L, and for H5C1185 it is on
the order of 100 pmol/L.
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the sample. Although this technique has been used with
amplification methods such as PCR and Q replicase,
this has not been previously demonstrated with NASBA.
Introducing a ligation step alongside a widely used, iso-
thermal, exponential amplification method adds another
strong tool for nucleic acid diagnostics.
The initial experiments showed the viability of the
LNASBA assay. Only when P3, P5, Target, T4 DNA Li-
gase, and the two primers were present was a 72-nt band
observed. In addition, we investigated the sensitivity of
the assay, which showed sensitivity down to the nanomo-
lar range. The experiments also showed that the product
concentrations were only slightly greater than the starting
Target concentrations, and thus a series of experiments
to explore possible optimizations were conducted.
Optimization of KCl concentration was performed to
find the optimal salt condition for amplification. By varying
KCl concentrations between 40 and 70 mmol/L, it was
found that 40 mmol/L was the optimal concentration for
amplification. This implies that the increased T7 RNA
polymerase activity outweighed the decrease in effi-
ciency of AMV-RT and RNase H even at lower concen-
trations of starting material in which the cyclic portion of
the amplification would be dominant and would rely on
AMV-RT and RNase H more heavily. We also studied the
Figure 8. A: The LNASBA assay with target or SNP target at a concentration of
0.15 mol/L. P3 and P5 concentrations were each varied between 0 and 0.35
mol/L. In the presence of SNP target, T4 DNA ligase does not ligate P3 and P5
together. Only lanes with target show the expected product band (Lanes 4, 6,
and 8), highlighted by boxed area. B: Graph showing the effect of increasing P3
and P5 starting concentrations on the 72-nt RNA product concentration. Despite
the decreased intensity bands on the pseudogel, there is an increase in product
concentration with increased P3 and P5 concentrations.effects of adjusting the ratio of P5 to P3 and found thatincreasing the P5 to P3 ratio to at least 3.66:1 improved
sensitivity. Because unligated P5 can still bind to Primer
1, a significant portion of available Primer 1 molecules
could be sequestered from full-length Probe, limiting its
amplification. We observed that increasing Primer 1 con-
centrations improved the assay and resulted in more
robust amplification of full-length probe. We believed that
the ligation step could also be improved by increasing
the number of nucleotides that are reverse complemen-
tary to the target. To investigate this possibility, we de-
signed an extended oligo set (H5C1185) and observed
that, with this extended set, LNASBA resulted in higher
sensitivity and a lower limit of target detection, on the
order of 100 pmol/L, compared with that of LNASBA with
the original oligo set H5G1192.
Our results also show that this assay can be developed
to differentiate between two sequences differing by an
SNP. In experiments in which Target and SNP Target
were exchanged in varying P3 and P5 concentrations,
conditions involving the SNP Target showed no 72-nt
product, whereas a positive signal was seen in all sam-
ples with Target. This shows the strength of including a
ligation step, as it prevents false-positive results due to
even a single base change. This great specificity along-
side NASBA opens up a powerful option for nucleic acid
diagnostics.
The SNP experimental results are very useful when
difference a SNP is needed. One example in nature
where this occurs is the difference between H1 seasonal
flu and H1 swine flu. Although the viruses are very similar
sequences, the clinical symptoms of the disease are
different and could require different patient treatment
protocols. With the viral RNA target sequences in mind,
we can design probes that are very specific and would
result in highly sensitive detection. For example, if vRNA
sequence 1 is 5=–AUAUGGGA3= and sequence 2 is
5=–AUAUCGGA3=, we can design a set of probes for
each particular sequence that are designed to ligate at
the SNP location and that allow us to identify which se-
quence is being detected. This could also be useful in
multiplex detection, which would also be a focus of future
papers. As for the advantage of LNASBA specificity over
standard NASBA, we believe that NASBA probes not
requiring ligation would have more difficulty in differenti-
ating between SNP targets. Continuing with the previous
examples of sequences 1 and 2, if we designed a NASBA
probe to bind to one target sequence, it is likely that it
would either bind to the other, because of the high
degree of conservation between the two, or that the
binding efficiency is suboptimal to reduce false-posi-
tive results. A direct comparison would be the best way
to quantify the advantage, and will be part of future
experiments.
Finally, in this investigation, the amplifiable probe in the
assay has been previously shown to bind to influenza H5
viral RNA. In turn, this assay is relevant to clinical prob-
lems. With the flexibility of probe and primer sequences
that LNASBA allows the user to control, the assay can be
used for detecting any number of nucleic acid targets.
Future experiments include designing probes for detec-
tion of clinical samples such as H1 viral RNA. These
Ligation with NASBA 213
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comparison with conventional NASBA techniques.
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